Literature DB >> 28973585

Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case-Control Study.

Isabel C Hostettler1, Varinder S Alg1, Nichole Shahi1, Fatima Jichi2, Stephen Bonner3, Daniel Walsh4, Diederik Bulters5, Neil Kitchen6, Martin M Brown1, Henry Houlden7, Joan Grieve6, David J Werring1.   

Abstract

BACKGROUND: Only a minority of intracranial aneurysms rupture to cause subarachnoid hemorrhage.
OBJECTIVE: To test the hypothesis that unruptured aneurysms have different characteristics and risk factor profiles compared to ruptured aneurysms.
METHODS: We recruited patients with unruptured aneurysms or aneurysmal subarachnoid hemorrhages at 22 UK hospitals between 2011 and 2014. Demographic, clinical, and imaging data were collected using standardized case report forms. We compared risk factors using multivariable logistic regression.
RESULTS: A total of 2334 patients (1729 with aneurysmal subarachnoid hemorrhage, 605 with unruptured aneurysms) were included (mean age 54.22 yr). In multivariable analyses, the following variables were independently associated with rupture status: black ethnicity (odds ratio [OR] 2.42; 95% confidence interval [CI] 1.29-4.56, compared to white) and aneurysm location (anterior cerebral artery/anterior communicating artery [OR 3.21; 95% CI 2.34-4.40], posterior communicating artery [OR 3.92; 95% CI 2.67-5.74], or posterior circulation [OR 3.12; 95% CI 2.08-4.70], compared to middle cerebral artery). The following variables were inversely associated with rupture status: antihypertensive medication (OR 0.65; 95% CI 0.49-0.84), hypercholesterolemia (0.64 OR; 95% CI 0.48-0.85), aspirin use (OR 0.28; 95% CI 0.20-0.40), internal carotid artery location (OR 0.53; 95% CI 0.38-0.75), and aneurysm size (per mm increase; OR 0.76; 95% CI 0.69-0.84).
CONCLUSION: We show substantial differences in patient and aneurysm characteristics between ruptured and unruptured aneurysms. These findings support the hypothesis that different pathological mechanisms are involved in the formation of ruptured aneurysms and incidentally detected unruptured aneurysms. The potential protective effect of aspirin might justify randomized prevention trials in patients with unruptured aneurysms.

Entities:  

Mesh:

Year:  2018        PMID: 28973585     DOI: 10.1093/neuros/nyx365

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Associations Between Drug Treatments and the Risk of Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-analysis.

Authors:  Kampei Shimizu; Tomohiro Aoki; Nima Etminan; Katharina A M Hackenberg; Shoichi Tani; Hirotoshi Imamura; Hiroharu Kataoka; Nobuyuki Sakai
Journal:  Transl Stroke Res       Date:  2022-10-15       Impact factor: 6.800

2.  Decreased contrast enhancement on high-resolution vessel wall imaging of unruptured intracranial aneurysms in patients taking aspirin.

Authors:  Jorge A Roa; Mario Zanaty; Daizo Ishii; Yongjun Lu; David K Kung; Robert M Starke; James C Torner; Pascal M Jabbour; Edgar A Samaniego; David M Hasan
Journal:  J Neurosurg       Date:  2020-03-06       Impact factor: 5.115

3.  Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage.

Authors:  Matthew J Morton; Isabel C Hostettler; Nabila Kazmi; Varinder S Alg; Stephen Bonner; Martin M Brown; Andrew Durnford; Benjamin Gaastra; Patrick Garland; Joan Grieve; Neil Kitchen; Daniel Walsh; Ardalan Zolnourian; Henry Houlden; Tom R Gaunt; Diederik O Bulters; David J Werring; Ian Galea
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-01-14       Impact factor: 10.154

4.  The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis.

Authors:  Torge Huckhagel; Regine Klinger; Nils Ole Schmidt; Jan Regelsberger; Manfred Westphal; Patrick Czorlich
Journal:  Acta Neurochir (Wien)       Date:  2020-02-04       Impact factor: 2.216

5.  Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture.

Authors:  Mikel Terceño; Sebastian Remollo; Yolanda Silva; Saima Bashir; Mariano Werner; Víctor A Vera-Monge; Joaquín Serena; Carlos Castaño
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 6.  Dyslipidemia and rupture risk of intracranial aneurysms-a systematic review.

Authors:  Katja Løvik; Johnny Laupsa-Borge; Nicola Logallo; Christian A Helland
Journal:  Neurosurg Rev       Date:  2021-03-11       Impact factor: 3.042

7.  Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome.

Authors:  Martina Sebök; Isabel C Hostettler; Emanuela Keller; Ilari M Rautalin; Bert A Coert; William P Vandertop; René Post; Ali Sardeha; Maud A Tjerkstra; Luca Regli; Dagmar Verbaan; Menno R Germans
Journal:  Int J Stroke       Date:  2021-07-29       Impact factor: 6.948

8.  ANGPTL6 Genetic Variants Are an Underlying Cause of Familial Intracranial Aneurysms.

Authors:  Isabel C Hostettler; Benjamin O'Callaghan; Enrico Bugiardini; Emer O'Connor; Jana Vandrovcova; Indran Davagnanam; Varinder Alg; Stephen Bonner; Daniel Walsh; Diederik Bulters; Neil Kitchen; Martin M Brown; Joan Grieve; David J Werring; Henry Houlden
Journal:  Neurology       Date:  2020-10-26       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.